Global Colorectal Cancer Screening Tests Market - Industry Analysis and Market Forecast 2017 - 2022 - Product Image

Global Colorectal Cancer Screening Tests Market - Industry Analysis and Market Forecast 2017 - 2022

  • ID: 4387363
  • Report
  • Region: Global
  • 199 pages
  • Mordor Intelligence
1 of 4
US Colorectal Cancer Screening Tests Rate to Rise Up to 80% by 2018

The American Cancer Society reports Colon Cancer diagnosis rate has dropped 30% in the US in the last 10 years for those aged 50 years and older. A coalition of more than 70 public, private, and voluntary organizations, led by the American Cancer Society and the Centers for Disease Control and Prevention (CDC), is joining together to focus efforts on dramatically increasing colon screening rates in the US to 80% by 2018.

Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women in the US. The findings published in Colorectal Cancer Statistics, 2014 report estimates that 136,830 people will be diagnosed with colon cancer and 50,310 people will die from it in 2014. Approximately 5% or 1 in 20 Americans will be diagnosed with colon cancer in their lifetime. As of January 1, 2012, there were almost 1.2 million colon cancer survivors in the US.

Advances in diagnosis and treatment of colorectal cancer have increased survival over the last decade. According to the CDCs Behavioral Risk Factor Surveillance System, nearly 70% of adults aged 50 to 74 years are up to date with colorectal cancer screening. The Colorectal Cancer screening market for US is estimated to be USD 1.4 billion in 2013 and expected to grow ten times in a decade.

This report provides the Colorectal Cancer Screening Tests Market Forecasting Model, offers valuable insights on global evolution, regional variation, and current market trends. The report also provides Company Profiles with Pipeline Products and financials. Most of the products are being developed collaboratively between pharmaceutical and diagnostics companies.

Scope:

1) Global Market evolution, strategic assessment of Indications market impact analysis, future market and company analysis

2) Competitive Assessment including Pipeline Product approval analysis

3) Coverage of Major Players includes company profiles, financials and major products and services.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1 Introduction
1.1 Report Description
1.2 Research Methodology
2 Colorectal Cancer Screening Tests Market Overview
2.1 Global Colorectal Cancer Screening Tests Introduction
2.1.1 Context and Background
2.1.2 Diagnosis, Treatment and Management
2.1.3 Colorectal Cancer Screening Tests Methods
2.1.4 Colorectal Cancer Screening Tests Regulatory Framework
2.1.4.1 Europe Regulation
2.1.4.2 United States Regulation
3 Global Colorectal Cancer Screening Tests - Market Forces
3.1 Market Drivers
3.1.1 Increase of Pipeline Colorectal Cancer Screening Tests
3.1.2 Aging Population
3.1.3 Increasing Consumer Awareness
3.2 Market Restraints
3.2.1 Screening Tests Cost
3.2.2 Counseling
3.3 Opportunities
3.3.1 New Tests and Approaches in Development
4 Global Colorectal Cancer Screening Tests Market, By Tests
4.1 Overview
4.1.1 Global Colorectal Cancer Screening Tests Market, By Tests, 2014-2020
4.2 Blood Tests
4.2.1 Global Blood Tests Market, 2014-2020
4.3 Fecal Tests
4.3.1 Global Fecal Tests Market, 2014-2020
4.4 Colonoscopy
4.4.1 Global Colonoscopy Market, 2014-2020
4.5 Flexible Sigmoidoscopy
4.5.1 Global Flexible Sigmoidoscopy Market, 2014-2020
5 Colorectal Cancer Screening Tests Market, by Geography
5.1 Overview
5.1.1 Global Colorectal Cancer Screening Tests Market, by Geography, 2014-2020
5.1.2 Colorectal Cancer Screening Tests Market Comparative Analysis, by Geography, 2013&2020
5.2 North America
5.2.1 North America Colorectal Cancer Screening Tests Market, 2014-2020
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.3 Europe
5.3.1 Europe Colorectal Cancer Screening Tests Market, 2014-2020
5.3.1.1 France
5.3.1.2 Germany
5.3.1.3 Italy
5.3.1.4 Spain
5.3.1.5 United Kingdom
5.4 Asia-Pacific
5.4.1 Asia-Pacific Colorectal Cancer Screening Tests Market, 2014-2020
5.4.1.1 China
5.4.1.2 India
5.4.1.3 Japan
5.5 RoW
5.5.1 RoW Colorectal Cancer Screening Tests Market, by Type, 2014-2020
6 Colorectal Cancer Screening Tests Market Share Analysis
6.1 Key Players Global Market Share Analysis
6.1.1 Global Colorectal Cancer Screening Tests Market Share Analysis, by Key Players, 2013
6.1.2 Global Colorectal Cancer Screening Tests Market, Key Players by Segment
7 Competitive Landscape
7.1 New Product Innovations
7.2 Agreements, Partnerships, Joint Ventures and Collaborations
7.3 Mergers & Acquisitions
8 Company Profiles
8.1 Abbott Diagnostics
8.1.1 Overview
8.1.2 Major Products and Services
8.1.3 Colorectal Cancer Screening Tests Pipeline Products
8.1.4 Financials
8.1.5 Developments
8.2 Alere
8.2.1 Overview
8.2.2 Major Products and Services
8.2.3 Colorectal Cancer Screening Tests Pipeline Products
8.2.4 Financials
8.2.5 Developments
8.3 Beckman Coulter
8.3.1 Overview
8.3.2 Major Products and Services
8.3.3 Colorectal Cancer Screening Tests Pipeline Products
8.3.4 Financials
8.3.5 Developments
8.4 Clinical Genomics
8.4.1 Overview
8.4.2 Major Products and Services
8.4.3 Colorectal Cancer Screening Tests Pipeline Products
8.4.4 Financials
8.4.5 Developments
8.5 Companion Dx
8.5.1 Overview
8.5.2 Major Products and Services
8.5.3 Colorectal Cancer Screening Tests Pipeline Products
8.5.4 Financials
8.5.5 Developments
8.6 EDP Biotech
8.6.1 Overview
8.6.2 Major Products and Services
8.6.3 Colorectal Cancer Screening Tests Pipeline Products
8.6.4 Financials
8.6.5 Developments
8.7 Epigenomics AG
8.7.1 Overview
8.7.2 Major Products and Services
8.7.3 Colorectal Cancer Screening Tests Pipeline Products
8.7.4 Financials
8.7.5 Developments
8.8 Exact Sciences
8.8.1 Overview
8.8.2 Major Products and Services
8.8.3 Colorectal Cancer Screening Tests Pipeline Products
8.8.4 Financials
8.8.5 Developments
8.9 Fujirebio (Miraca Holdings)
8.9.1 Overview
8.9.2 Major Products and Services
8.9.3 Colorectal Cancer Screening Tests Pipeline Products
8.9.4 Financials
8.9.5 Developments
8.10 Genomic Tree
8.10.1 Overview
8.10.2 Major Products and Services
8.10.3 Colorectal Cancer Screening Tests Pipeline Products
8.10.4 Financials
8.10.5 Developments
8.11 Metabiomics
8.11.1 Overview
8.11.2 Major Products and Services
8.11.3 Colorectal Cancer Screening Tests Pipeline Products
8.11.4 Financials
8.11.5 Developments
8.12 Oncocyte (Biotime)
8.12.1 Overview
8.12.2 Major Products and Services
8.12.3 Colorectal Cancer Screening Tests Pipeline Products
8.12.4 Financials
8.12.5 Developments
8.13 Quest Diagnostics
8.13.1 Overview
8.13.2 Major Products and Services
8.13.3 Colorectal Cancer Screening Tests Pipeline Products
8.13.4 Financials
8.13.5 Developments
8.14 Randox Laboratories
8.14.1 Overview
8.14.2 Major Products and Services
8.14.3 Colorectal Cancer Screening Tests Pipeline Products
8.14.4 Financials
8.14.5 Developments
8.15 Siemens Healthcare
8.15.1 Overview
8.15.2 Major Products and Services
8.15.3 Colorectal Cancer Screening Tests Pipeline Products
8.15.4 Financials
8.15.5 Developments
8.16 Volition Rx
8.16.1 Overview
8.16.2 Major Products and Services
8.16.3 Colorectal Cancer Screening Tests Pipeline Products
8.16.4 Financials
8.16.5 Developments
9 Appendix
9.1 Abbreviations
9.2 Sources
9.3 Bibliography
9.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll